SMP Receives FDA Approval for the Reactor®
Sharp Medical Products, LLC Receives FDA Approval for the Reactor® Chest Tube Insertion Device
Geneva, IL – Sharp Medical Products, LLC, a privately held company and maker of the Reactor®, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Reactor Chest Tube Insertion Device for commercial distribution. The Reactor® offers medical professionals a revolutionary way to insert chest tubes into the thoracic cavity to drain blood, air or an infection. Placement of a chest tube into the thoracic cavity has been around for more than 100 years with virtually no change in technique – until now!
Some of the design features of the Reactor® to markedly improve the insertion of chest tubes includes:
- Rotating and retracting blade (carves not punctures through tissue)
- Oval shaft (fits between ribs better than round)
- Chest wall tunnel – (creates a constant diameter narrow tunnel of ~ 1 cm)
Potential advantages of the Reactor® include smaller incision and faster procedure times. Other advantages may become clear with time.
“We are ecstatic to have received our FDA approval to begin to market and sell the Reactor®,” said Dave Sash, National Sales Director for Sharp Medical Products. “The Reactor® is truly one of those unique medical devices that can help revolutionize medicine – it is not an incremental change but a quantum leap improvement for the insertion of chest tubes into the thoracic cavity – the present method has been around for more than 100 years with virtually no improvement.”
Sharp Medical Products, LLC. was founded by a U.S. surgeon. Both U.S. and international patents have been issued. For more information visit www.sharpmedicalproducts.com or call 630-232-8002.